<SEC-DOCUMENT>0001104659-20-087999-index.html : 20200804 <SEC-HEADER>0001104659-20-087999.hdr.sgml : 20200804 <ACCEPTANCE-DATETIME>20200729215355 ACCESSION NUMBER: 0001104659-20-087999 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20200729 DATE AS OF CHANGE: 20200729 EFFECTIVENESS DATE: 20200730 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-240178 FILM NUMBER: 201058961 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>tm2025639d1_s8.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: tm2025639d1_s8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>tm2025639d1_ex5-1.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: tm2025639d1_ex5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>3 <FILENAME>tm2025639d1_ex23-2.htm <DESCRIPTION>EXHIBIT 23.2 <TEXT> Document 3 - file: tm2025639d1_ex23-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>tm2025639d1_ex99-1.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 4 - file: tm2025639d1_ex99-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>tm2025639d1_ex5-1img001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: tm2025639d1_ex5-1img001.jpg
</DOCUMENT> </SEC-DOCUMENT>